Masimo Corporation (MASI) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in Irvine, CA, United States. Der aktuelle CEO ist Catherine Szyman.
MASI hat IPO-Datum 2007-08-08, 3,600 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $9.34B.
Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions. The company's core offerings include advanced pulse oximetry systems with its proprietary signal extraction technology, the Masimo rainbow SET platform for comprehensive hemoglobin monitoring, brain function monitoring via SedLine, capnography and gas monitoring products, and regional tissue oximetry solutions. Additionally, Masimo provides its Hospital Automation platform featuring patient safety and surveillance systems, along with connectivity devices and ventilation solutions. The company serves hospitals, emergency medical services, home care providers, long-term care facilities, and consumers through direct sales, distributors, and original equipment manufacturer partnerships. Founded in 1989 and headquartered in Irvine, California, Masimo has established itself as a leader in patient monitoring and clinical automation technologies.
